Sputnik V Vaccine Study Published in Lancet

The medical journal Lancet published today the Russian Phase I and II studies on their Sputnik V COVID-19 vaccine, showing that 100% of the 76 volunteers developed antibodies at the appropriate levels. The side effects were mild fevers and headaches. By Russian law, the medical data must first be submitted to the government for examination and registration, prior to publication. When the registration occurred last month, there was a massive uproar in the West over the lack of publication in a medical journal, but everything has proceeded exactly according to the proper procedure in Russia.